文献速递血脂与心血管预防

美国医疗系统中年轻成人血脂随访检测与他汀起始治疗的模式

Follow-Up Lipid Testing and Statin Initiation Among Young Adults in a U.S. Health Care System.
PubMed 文献 · J Am Coll Cardiol · 2025-11-10

本研究基于Kaiser Permanente南加州医疗系统2008-2020年18-39岁首次LDL-C升高者771,681例,评估1、2、5年内随访血脂检测和他汀起始比例及2008-2018年趋势。结果显示高风险年轻成人他汀起始率低,且1年内随访检测和他汀起始率随时间下降,提示年轻成人血脂管理存在照护缺口。

要点

  • LDL-C≥190 mg/dL的年轻成人1年内他汀起始率仅28.4%,5年内45.7%。
  • 2008-2018年,高风险亚组1年内随访LDL-C检测率和他汀起始率均下降。
  • 年轻成人LDL-C升高后随访检测和他汀起始不足,存在错过早期干预机会。

核心结论

  • 年轻成人LDL-C升高后随访血脂检测和他汀起始率低,且2008-2018年1年内检测和起始率下降,提示血脂管理照护缺口。

研究设计与样本

  • 基于Kaiser Permanente南加州医疗系统的回顾性队列研究,纳入2008-2020年首次LDL-C升高的18-39岁成员共771,681例。

主要发现

  • 队列中65.9%、25.3%、6.9%、1.9%的首次LDL-C分别为100-129、130-159、160-189、≥190 mg/dL。
  • LDL-C≥190 mg/dL者1、2、5年内他汀起始率分别为28.4%、33.5%、45.7%。
  • LDL-C 160-189 mg/dL且30年ASCVD高风险者1、2、5年内他汀起始率分别为25.3%、31.9%、46.4%。
  • LDL-C≥190 mg/dL者1、2、5年内他汀起始率分别为44.1%、50.2%、61.5%。
  • 2008-2018年,LDL-C 160-189 mg/dL且30年高风险者1年内随访LDL-C检测率从52.5%降至35.4%。

关键数值与推荐

  • 高风险亚组定义为LDL-C≥190 mg/dL或LDL-C 160-189 mg/dL且30年ASCVD高风险。
  • 2008-2018年,两个高风险亚组1年内他汀起始率分别从31.7%和36.5%降至20.1%和12.6%。

临床怎么用

  • 对年轻成人LDL-C升高应加强随访检测,尤其高风险者需及时评估并启动他汀以降低累积LDL-C暴露。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: More than 50% of U.S. young adults have low-density lipoprotein cholesterol (LDL-C) ≥100 mg/dL, and young adults are less likely to be aware of their high LDL-C levels compared with older age adults. OBJECTIVES: This study examined patterns of LDL-C testing and statin initiation following an initial elevated LDL-C measurement and assessed temporal trends of LDL-C testing and statin initiation from 2008 to 2018. METHODS: We identified Kaiser Permanente Southern California members aged 18 to 39 years with their first elevated LDL-C measurement (index) between 2008 and 2020. We examined the proportion of young adults with a follow-up LDL-C test and statin initiation within 1, 2, and 5 years after the index LDL-C measurement, overall, and stratified by high-risk subgroups. We also assessed the temporal trends of follow-up LDL-C testing and statin initiation within 1 year of an elevated LDL-C measurement from 2008 to 2018 among high-risk subgroups: 1) LDL-C ≥190 mg/dL; and 2) LDL-C 160 to 189 mg/dL and high estimated 30-year atherosclerotic cardiovascular disease (ASCVD) risk. RESULTS: Among 771,681 young adults, 65.9%, 25.3%, 6.9%, and 1.9% had an index LDL-C of 100 to 129 mg/dL, 130 to 159 mg/dL, 160 to 189 mg/dL, and ≥190 mg/dL, respectively. Among those with LDL-C ≥190 mg/dL, 28.4%, 33.5%, and 45.7% initiated a statin within 1, 2, and 5 years, respectively. The proportions of young adults with 30-year high ASCVD risk and LDL-C ≥160 to 189 mg/dL who initiated a statin were 25.3%, 31.9%, and 46.4% within 1, 2 and 5 years, and 44.1%, 50.2%, and 61.5% within 1, 2, and 5 years, respectively, among those with LDL-C ≥190 mg/dL. Follow-up LDL-C testing within 1 year declined between 2008 and 2018, from 52.5% to 35.4% among those with LDL-C 160 to 189 mg/dL and high 30-year risk. Statin initiation within 1 year also declined in both high-risk subgroups from 31.7% and 36.5% in 2008 to 20.1% and 12.6% in 2018. CONCLUSIONS: These findings suggest care gaps in lipid management of young adults with elevated LDL-C and represent missed opportunities to reduce cumulative LDL-C exposure and to prevent premature ASCVD during a critical window of vulnerability.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Harrison TN, Zhang Y, Choi SK, et al. Follow-Up Lipid Testing and Statin Initiation Among Young Adults in a U.S. Health Care System. J Am Coll Cardiol. 2025. PMID: 41384892. doi:10.1016/j.jacc.2025.10.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。